Table 7 Univariate regression analysis of factors affecting asthma control

From: Opportunities to develop the professional role of community pharmacists in the care of patients with asthma: a cross-sectional study

Variables

Odds ratio

95% Confidence interval

P-value

Gender

 Female versus male

1.41

0.83–2.40

0.2072

Age

 1-s.d. increase (19.63 years)

1.43

1.10–1.84

0.0068

IRSAD

 1-s.d. increase (39.55 points)

1.16

0.91–1.50

0.2338

Written asthma action plan

 Yes versus no

1.02

0.51–2.01

0.9641

Overall quality of life score

 One-point increase

22.35

9.27–53.88

<0.0001

Overall medication adherence scores

 One-point increase

1.00

0.96–1.03

0.8098

Overall asthma knowledge score

 One-point increase

0.98

0.84–1.14

0.7955

Patient beliefs score

 One-point increase

0.89

0.84–0.94

<0.0001

On ICS medication

 Yes versus no

2.42

1.34–4.35

0.0033

Current smoker

 Yes versus no

2.23

1.14–4.36

0.0189

Hay fever

 Yes versus no

1.28

0.77–2.12

0.3410

Sinusitis

 Yes versus no

2.69

1.32–5.49

0.0065

Combination ICS/LABA

 Yes versus no

1.54

0.92–2.57

0.0998

  1. Abbreviations: ICS, inhaled corticosteroid; IRSAD, Index of Relative Socio-economic Advantage and Disadvantage; LABA, long-acting β2-agonist.